Prognostic Significance of Mucin and p53 Expression in Stage IB Non-Small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

INTRODUCTION: CALGB 9633 was a Phase III trial that randomized patients with stage IB non-small cell lung cancer (NSCLC) to observation or four cycles of carboplatin and paclitaxel. A statistically significant effect in favor of adjuvant chemotherapy was seen for disease-free survival (DFS) and over...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Graziano, Stephen L., Gu, Lin, Wang, Xiaofei, Tatum, Arthur H., Vollmer, Robin T., Strauss, Gary M., Kratzke, Robert, Dudek, Arkadiusz Z., Vokes, Everett E, Green, Mark R.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3505667/
https://ncbi.nlm.nih.gov/pubmed/20521348
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires